ACS Pharmacotherapy Personalization Tool

Clinical calculation support · Verify results before clinical use

Patient and treatment factors

Complete all six fields, then calculate the considerations.

Choose the current working diagnosis.

Use a validated assessment and clinical judgement where appropriate.

Reset form

Clinical context and limitations

This tool organizes selected pharmacotherapy considerations for adults with ACS. It does not calculate drug doses or independently establish eligibility for any treatment.

Important checks before prescribing

  • Confirm diagnosis, reperfusion strategy, timing, hemodynamic stability, and any planned invasive procedure.
  • Review bleeding history, prior stroke or TIA, body weight, allergies, drug interactions, and contraindications to antithrombotic therapy.
  • Verify renal function and potassium, particularly before anticoagulants, ACE inhibitors/ARBs, or mineralocorticoid receptor antagonists.
  • Reassess antithrombotic combinations and duration after PCI when long-term oral anticoagulation is required.
  • Do not initiate beta-blockers during cardiogenic shock or acute decompensated heart failure; reassess once stable.

References

Rao SV, O'Donoghue ML, Ruel M, et al.

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology. 2025.

doi:10.1016/j.jacc.2024.11.009

Byrne RA, Rossello X, Coughlan JJ, et al.

2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023;44:3720–3826.

doi:10.1093/eurheartj/ehad191

American Heart Association / American College of Cardiology.

2025 ACS Guideline: Top Things to Know and supporting clinical guidance.

Official guideline summary

Clinical disclaimer: This tool is intended for qualified healthcare professionals as a decision-support aid. It is not a substitute for current guideline review, institutional protocols, specialist consultation, or patient-specific clinical judgement. Treatment must be individualized and verified before prescribing. The selected fields are incomplete clinical data and cannot safely determine all treatment decisions.